VR motor training to improve strength, balance, and control in adults with autism

Motor Function Assessment and VR-based Motor Training in Adults With Autism Spectrum Disorder

Not applicable Interventional National Taiwan University Hospital · NCT07134569

This trial tests whether a 6-week virtual reality motor training program can improve muscle strength, balance, and motor control in adults with autism compared with non-autistic controls.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment200 (estimated)
Ages18 Years to 45 Years
SexAll
SponsorNational Taiwan University Hospital Academic / other
Locations1 site (Taipei)
Trial IDNCT07134569 on ClinicalTrials.gov

What this trial studies

Researchers will enroll adults aged 18–45 with autism and a matched non-ASD comparison group to measure baseline motor, cognitive, and brain-activation profiles. Participants will undergo a 6-week VR-based motor training program, with standardized motor function tests before and after the intervention. The study will compare changes in muscle strength, balance, motor control, and related cognitive or neural activation between the ASD and control groups. Outcomes will determine whether the VR training produces measurable improvements in motor and brain function in adults with autism.

Who should consider this trial

Good fit: Ideal candidates are motivated adults aged 18–45 with a DSM-5 diagnosis of autism, full-scale IQ > 70, and no major psychiatric, neurological, visual, or hearing conditions that would prevent participation.

Not a fit: People outside the 18–45 age range, with IQ ≤ 70, significant psychiatric or neurological disorders, or sensory impairments that prevent VR participation are unlikely to benefit from this program.

Why it matters

Potential benefit: If successful, the VR training could improve muscle strength, balance, and motor control and thereby help daily function and independence for adults with autism.

How similar studies have performed: Smaller pilot studies and work in children or mixed-age groups using VR or focused motor training have shown promising improvements in motor skills, but rigorous large-scale adult ASD trials remain limited.

Eligibility criteria

Show full inclusion / exclusion criteria
\> The ASD Group

Inclusion criteria:

* young adult aged between 18 and 45 years who had a diagnosis of ASD from a licensed mental health or medical professional based on DSM-5.
* was motivated to complete the 6-week VR-based motor function training.
* had a full-scale IQ \> 70 on the WAIS-IV.

Exclusion criteria:

* a history of major mental illness (e.g., bipolar affective disorder, schizophrenia, or psychosis), neurological diseases (e.g., stroke, lumbar radiculopathy, or spinal cord injury) that hamper walking function, or neurosurgery.
* visual impairment and/or hearing impairment that would preclude participation in motor assessment or training.

  * The Non-ASD control group

Inclusion criteria:

* young adult aged between 18 and 45 years who do not have a diagnosis of ASD.
* had a full-scale IQ \> 70 on the WAIS-IV.

Exclusion criteria:

* a history of major mental illness (e.g., bipolar affective disorder, schizophrenia, or psychosis), neurological diseases (e.g., stroke, lumbar radiculopathy, or spinal cord injury), or neurosurgery that hamper walking function.
* visual impairment and/or hearing impairment that would preclude participation in motor assessment or training.

Where this trial is running

Taipei

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions AutismVirtual Realitymotor training
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.